Using tumor organoids to guide treatment for advanced cancers
Part of Cancer clinical trials.
This study tests whether growing a patient's tumor cells in a dish (called an organoid) can help doctors choose the best next treatment. It is for people with advanced colorectal or pancreatic cancer who have run out of standard options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have advanced colorectal or pancreatic cancer that cannot be removed by surgery
- You must have already tried or cannot take standard treatments for your cancer type
- You must have at least one tumor that can be safely biopsied (not in the lung)
- You must be well enough to have a performance status of 0 or 1 (able to carry out daily activities)
- You must have adequate liver, kidney, and blood cell counts
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses advanced testing (genetic sequencing and lab-grown tumor models) to find the best treatment for people with advanced solid tumors that haven't responded to at least one standard treatment. The goal is to personalize therapy based on your tumor's unique features.
This trial tests whether using a miniature version of your tumor grown in a lab can help choose the best treatment for advanced breast cancer. It compares this personalized approach to standard care.
This study is creating lab-grown mini-tumors (organoids) from your cancer to help doctors choose the best treatment for you. If you have a rare undifferentiated primary carcinoma, your tumor sample could be used to test different drugs before you receive them.
This trial tests whether using a personalized approach—growing your tumor cells in the lab to find the best treatment—can work better than standard treatments chosen by your doctor. It is for people with advanced breast cancer that has stopped responding to at least two previous treatments.
This trial uses a lab test on a tiny sample of your tumor (called an organoid) to find which drug might work best for your advanced prostate cancer. It's for men whose cancer has stopped responding to hormone therapy and got worse after first treatment.
This trial grows a lab model from your own tumor tissue (or resected tissue) to predict which drugs might work best. It’s meant to match investigational treatments to your specific tumor biology.
Hear when a new Advanced, Pretreated Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.